Detailed Analysis of Charlson Comorbidity Score as Predictor of Mortality After Radical Prostatectomy

Urology

Volumn 72, Issue 6, 2008, Pages 1252-1257

  Froehner, Michael ^a   Koch, Rainer ^a   Litz, Rainer J ^a   Oehlschlaeger, Sven ^a   Twelker, Lars ^a   Hakenberg, Oliver W ^b   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR DISEASE; CLINICAL DECISION MAKING; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; HEART INFARCTION; HEMIPLEGIA; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM;

AGE FACTORS; AGED; COMORBIDITY; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 56449126400     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.05.037     Document Type: Article

References (18)

1. Klein E.A. What is "insignificant" prostate carcinoma?. Cancer 101 (2004) 1923-1925
2. Adolfsson J., Tribukait B., and Levitt S. The 20-yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: The prognostic value of tumour ploidy and comorbidity. Eur Urol 52 (2007) 1028-1035
3. Singh R., and O'Brien T.S. Comorbidity assessment in localized prostate cancer: A review of currently available techniques. Eur Urol 46 (2004) 28-41
4. Kastner C., Armitage J., Kimble A., et al. The Charlson comorbidity score: A superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting. Prostate Cancer Prostatic Dis 9 (2006) 270-274
5. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 40 (1987) 373-383
6. Froehner M., Koch R., Litz R., et al. Which conditions contributing to the Charlson score predict survival after radical prostatectomy?. J Urol 171 (2004) 697-699
7. The Cochran Foundation. Cardiovascular Disease Classification Chart. http://www.cochranfoundation.com/docs/nyha-class.htm Accessed April 28, 2008.
8. Froehner M., Koch R., Litz R., et al. Interaction between age and comorbidity as predictors of mortality after radical prostatectomy. J Urol 179 (2008) 1823-1829
9. Thompson I., Thrasher J.B., Aus G., et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177 (2007) 2106-2131
10. Heidenreich A., Aus G., Abbou C.C., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
11. de Vries S.H., Raaijmakers R., Kranse R., et al. Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy. J Urol 172 (2004) 2193-2196
12. Froehner M., Koch R., Litz R., et al. Comorbidity is a poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age. Urology 68 (2006) 583-586
13. Tewari A., Johnson C.C., Divine G., et al. Long-term survival probability in men with clinically localized prostate cancer: A case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 171 (2004) 1513-1519
14. Barry M.J., Albertsen P.C., Bagshaw M.A., et al. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: A retrospective analysis. Cancer 91 (2001) 2302-2314
15. Walz J., Gallina A., Saad F., et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 25 (2007) 3576-3581
16. Jeldres C., Suardi N., Walz J., et al. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: A population-based study of 6183 men. Eur Urol 54 (2008) 107-117
17. Statistics Canada. Life tables, Canada, provinces and territories: 2000-02. http://dsp-psd.pwgsc.gc.ca/Collection/Statcan/84-537-X/84-537-XIE.html No. 84-537-XIE. Accessed April 28, 2008.
18. Weiland S.K., Rapp K., Klenk J., et al. Increase of life expectancy in Germany: Magnitude, determinants and perspectives. [German]. Dtsch Ärztebl 103 (2006) A1072-A1077